Replies to post #1277 on Vascular Biogenics Ltd (VBLT)

[mantoo123]

Great post. I share your sentiments.

While there are several hints pointing at VB-111 trial success, they are all worthless unless VB-111 obtains FDA approval.

[gr8db8]

Agree wcopeland. Those are all good "signs" (including DSMC decisions) but none of them can conclusively say ph3 will pass. Only ph3 patient outcome will determine that. But the FDA can bend the rules a little bit like they did with avastin, which, as we all know, does not improve mOS.